Viennese APEIRON Biologics and MaxCyte Inc have entered into licensing agreement covering the use of Maxcyte’s...
Up To Date
Latest News
After closing the business merging with blank check company Arya Sciences Acquisition Corp, Immatics Inc has...
A new insulin formulation allows patients with diabetes to more quickly manage their blood sugar levels during...
Data from the UK’s RECOVERY trial demonstrate there was no clinical benefit from use of lopinavir-ritonavir in...
Under the Coronavirus Global Response Framework, the European Commission is allocating further €4.9bn to...
BioGeneration Ventures has closed its fourth VC fund for European start-ups (BGV IV) at €105m.
Share
